Company: JUNS
Filing Date: 2025-11-07
Form Type: DEFA14A
Source: 0001493152-25-021317
Chunk: 2

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-07
Form: DEFA14A
Chunk 2
---
 million aggregate purchase commitment made by Yorkville
under the SEPA, which includes amounts that are used as Advance Repayments of outstanding amounts under the Convertible Notes, and as
many shares of Common Stock as will be necessary to enable Yorkville to convert all outstanding amounts under the Convertible Notes that
Yorkville elects to convert into shares of Common Stock under the terms of the Convertible Notes, in each case, without any further aggregate
share issuance limitations under Nasdaq rules. However, the 6,855,459 share Exchange Cap will
continue to limit issuances and sales of Common Stock by the Company to Yorkville under the SEPA and upon conversion of the Convertible
Notes, unless and until the Company has obtained such requisite stockholder approval to issue shares of Common Stock in excess of the
Exchange Cap to Yorkville under the SEPA and upon conversion of the Convertible Notes in accordance with applicable Nasdaq rules.

Page 46: In Proposal No. 5, the maximum
number of shares of the Company’s Common Stock that the Company may issue unless the Company obtains the requisite stockholder approval
to issue shares of Common Stock in excess of the Exchange Cap to Yorkville under the SEPA and upon conversion of the Convertible Notes
in accordance with applicable Nasdaq rules is amended and restated in the following paragraphs to read as follows (corrections are marked,
with new text bold and underlined, and deleted text stricken through):

Pursuant to Nasdaq Listing Rule 5635(d), stockholder
approval is also required prior to a 20% or more of the Common Stock or 20% or more of the voting power outstanding before the issuance
at a price that is less than the Minimum Price. “Minimum Price” is defined as the lower of (i) the Nasdaq Official
Closing Price (as reflected on Nasdaq.com) immediately preceding the signing of the binding agreement; or (ii) the average Nasdaq Official
Closing Price of the Common Stock (as reflected on Nasdaq.com) for the five (5) trading days immediately preceding the signing of the
binding agreement. Shares of our Common Stock issuable upon conversion of debt instruments, such as the Convertible Notes, in such non-public
offerings are considered shares issued in such a transaction in determining whether the 20% limit has been reached. Based on the signing
of the SEPA on October 24, 2025, the applicable “Minimum Price” is $1.48 per